BRITTANY HENDRIX: Open Payments
NPI 1871057257 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 49 payments from 14 companies in 2025. Trend: 2023 $645 · 2024 $1,115 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $136 |
| PFIZER INC. | 6 | $117 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Lundbeck LLC | 5 | $80 |
| Amgen Inc. | 4 | $77 |
| SANOFI-AVENTIS U.S. LLC | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: NURTEC ODT, REXULTI, OTEZLA, FARXIGA, Rybelsus, TZIELD, Kerendia, UBRELVY.
Industry payments across AL — which companies pay providers there.
